TAKE Solutions has outlined a comprehensive strategic plan to build an advanced AI-driven diagnostic and preventive care platform as part of its long-term value creation roadmap. The company is targeting India's rapidly growing USD 197 billion preventive healthcare market, positioning itself at the forefront of healthcare transformation.

Strategic Roadmap and Value Creation Focus

The company's strategic initiative represents a significant expansion into India's preventive healthcare sector, with the platform designed to serve as a cornerstone of long-term value creation. This comprehensive approach aims to leverage artificial intelligence to revolutionize diagnostic and preventive care delivery across India's healthcare ecosystem.

Market Opportunity and Growth Potential

India's preventive healthcare market presents substantial growth opportunities, with several key indicators highlighting the sector's potential:

The market dynamics reflect a structural shift in consumer behavior, with preventive care becoming essential rather than optional. India is experiencing rising lifestyle diseases, growing health awareness, and increasing disposable income, all contributing to the sector's expansion.

Health Challenges Driving Platform Development

The AI-driven platform aims to address significant health challenges prevalent in India's population:

These statistics create unprecedented demand for early detection and risk scoring tools, positioning AI-driven solutions as critical healthcare enablers within the company's value creation strategy.

Platform Design and Ecosystem Integration

The planned platform is designed to serve India's complete health ecosystem through multiple user categories:

The platform's goal extends beyond traditional healthcare delivery, aiming to bring sophisticated diagnostics and real-time preventive care to every household, not just hospitals and laboratories.

Leadership Vision and Strategic Direction

Vedamirtham Venkatesan, Executive Director CFO of TAKE Solutions, emphasized the platform's significance: "India is entering a golden decade of preventive health. Our AI platform is built to serve a nation of 1.4 billion people who need accessible, accurate, and affordable health intelligence."

The initiative represents TAKE Solutions' vision to shape healthcare's future as India transitions from treatment-focused systems to AI-led early detection, predictive diagnostics, and preventive care as part of a comprehensive value creation roadmap.

Take Solutions Limited has announced a change in its registered office location within Chennai, following approval from its Board of Directors on December 18, 2025. The relocation represents a corporate administrative action disclosed under regulatory compliance requirements.

Board Approval and Regulatory Compliance

The Board of Directors approved the shifting of the registered office during their meeting held on December 18, 2025. This decision has been communicated to stock exchanges in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Office Relocation Details

The company is moving its registered office from its current location to a new address within Chennai. The relocation details are as follows:

Implementation Timeline

The registered office shifting takes effect immediately from December 18, 2025. The company has notified both BSE Limited and National Stock Exchange of India Limited about this corporate action through formal disclosure letters.

Regulatory Notification

Take Solutions Limited has fulfilled its disclosure obligations by informing the stock exchanges about this administrative change. The notification was signed by Vedamirtham Venkatesan, Executive Director and CFO of the company, ensuring proper authorization and compliance with regulatory requirements.

This registered office relocation represents a routine corporate administrative action that maintains the company's operational presence within Chennai while updating its official business address for regulatory and correspondence purposes.